Staff Profile
Sola Akinbolade
Research Associate
- Email: sola.akinbolade@ncl.ac.uk
- Telephone: 0191 208 2256
- Address: NIHR Innovation Observatory
The Catalyst
Room 3.12, 3 Science Square
Newcastle Helix
Newcastle upon Tyne
NE4 5TG
I am a Research Associate in Evidence Synthesis and Horizon Scanning, and I work in a team to design and implement literature searches of electronic medical, health and social science bibliographic databases, and clinical trial and research registries to identify, monitor and produce reports on new and evolving health technologies which target unmet clinical needs.
I have previous experience working as a pharmacist within the community and hospital settings, as well as the pharmaceutical industry. I also had a brief stint at a clinical research organisation assisting the clinical research team in all aspects of patient recruitment, clinical trial activity and administration.
I am passionate about improving and supporting awareness and access to innovative (new or repurposed) medicines to prevent, diagnose and treat disease conditions and address areas of unmet medical need for the improvement for health and wellbeing.
Current projects/Interests
- COVID-19 (SARS-CoV-2) combination therapies.
- Drug repurposing for COVID-19 as an efficient approach to exploring new indications for several approved therapeutic agents towards the prevention and treatment of COVID-19.
- Medicines repurposing as a strategy to identify new uses for existing medicines outside their original licence.
- Ogunbayo D, Coughlan D, Fairbairn R, Akinbolade S. Classification System for Innovative Medicines in the Pipeline: New or Repurposed?. In: HTAi 2022. 2022, Utrecht, The Netherlands: Cambridge University Press.
- Akinbolade S, Coughlan D, Fairbairn R, McConkey G, Powell H, Ogunbayo D, Craig D. Combination therapies for COVID-19: An overview of the clinical trials landscape. British Journal of Clinical Pharmacology 2021, (ePub ahead of Print).
- Akinbolade O, Husband A, Forrest S, Todd A. Deprescribing in advanced illness. Progress in Palliative Care 2016, 24(5), 268-271.